Study of AXT-1003 in Subjects With Advanced Malignant Tumors.

Clinical trial NCT06484985 · RECRUITING

Trial details

NCT number: NCT06484985
Sponsor: Axter Therapeutics (Beijing) Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma Advanced Solid Tumor

Start date: 2024-09-04
Primary completion: 2027-03-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.